BPGAM
AMAG

BTG Pactual Global Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

BTG Pactual Global Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,100
Closed -$203K – 117
2015
Q3 		$203K Hold
5,100
– – 0.02% 164
2015
Q2 		$352K Sell
5,100
-900
-15% -$56.6K 0.02% 168
2015
Q1 		$328K Buy
+6,000
New +$286K 0.03% 163

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTG Pactual Global Asset Management's AMAG Position: Q4 2015 in Review

BTG Pactual Global Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 5,100 shares — an estimated $203K sold.

BTG Pactual Global Asset Management first reported a position in AMAG in Q1 2015 and held it in 3 quarters. The position peaked at $352K in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • BTG Pactual Global Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 5,100 AMAG Pharmaceuticals shares in Q4 2015, an estimated $203K.
  • BTG Pactual Global Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • BTG Pactual Global Asset Management's AMAG Pharmaceuticals position peaked at $352K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.